Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice
Immunotherapy has expanded treatment options for cancers with historically poor outcomes, yet a significant proportion of patients still fail to achieve durable clinical benefit. We defined the contribution of β-adrenergic receptor (βAR) signaling, a component of the stress response, on success of i...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2018-03-01
|
| Serier: | OncoImmunology |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.1080/2162402X.2017.1405205 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|